Shaily Engineering Plastics Q4 FY26 results (Jan–Mar 2026) and concall

Consumer Durables · Concall AI · Call held 20 May 2026

Company page: Shaily Engineering Plastics share price, financials & guidance record

Shaily Engineering Plastics reported strong Q4 FY26 results driven by robust healthcare segment growth and margin expansion. The company achieved significant milestones with the commercial launch of Semaglutide pen injectors in global markets and entry into the semiconductor supply chain. However, the consumer segment faced headwinds due to weaker market demand. Management is focused on scaling new capacities and diversifying into high-growth verticals, while maintaining confidence in sustainable and improving margins.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q4 FY26: revenue up 10.3%, net profit up 63.3% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26
Revenue	180	186	203	225	236 +31%	236 +27%	224 +10%
Expenses	148	148	155	164	168	173	161
EBITDA	31	38	48	61	68 +119%	64 +68%	63 +31%
Margin	17%	20%	24%	27%	29%	27%	28%
Other income	1	0	5	2	2	0	14
Interest	5	4	4	4	4	4	4
Depreciation	10	10	10	11	11	12	12
Profit before tax	18	24	38	48	55 +206%	48 +100%	61 +61%
Tax rate	26%	26%	23%	25%	25%	25%	20%
Net profit	13	18	30	36	41 +215%	36 +100%	49 +63%
EPS	2.93	3.95	6.43	7.83	8.93	7.76	10.59

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Consumer Durables earnings calls